When used in combination ACE inhibitors and ARBs are associated with an increased risk of symptomatic hypotension, acute renal failure and hyperkalemia and may increase mortality.

Conditions: Hypertension, High Blood Pressure (HBP), Diabetic Nephropathy, Heart Failure (HF)

Treatments: Angiotensin Converting Enzyme Inhibitors (ACEI), Angiotensin II Receptor Blockers (ARBs)